Terminated PHASE4 INTERVENTIONAL 2-arm NCT02203630

Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients

A Randomized Controlled Pilot Trial of Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients

Sponsor: National Center for Advancing Translational Sciences (NCATS)

Conditions Arrhythmia Sepsis Septic Shock Shock Tachycardia

Interventions Norepinephrine Phenylephrine

Updated 10 times since 2017 Last updated: May 15, 2018 Started: Aug 31, 2014 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow enrollment; Lack of support and equipoise

Other terminated trials from National Center for Advancing Translational Sciences (NCATS)

See all terminations from National Center for Advancing Translational Sciences (NCATS)

Other Arrhythmia trials with similar outcome

Browse all Arrhythmia trials

A PHASE4 clinical study on Arrhythmia and Sepsis, this trial is terminated or withdrawn. The trial is conducted by National Center for Advancing Translational Sciences (NCATS) and has accumulated 10 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE4
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE4
Oct 2022 — Dec 2022 [monthly]

Terminated PHASE4

▶ Show 5 earlier versions

Dec 2021 — Oct 2022 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Jul 2018 — Jan 2021 [monthly]

Terminated PHASE4

Status: Unknown Status → Terminated
Jun 2018 — Jul 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Advancing Translational Sciences (NCATS)
National Center for Research Resources (NCRR)
Vanderbilt University Medical Center

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States